KK8123

DRUG2 trials

Sponsors

Kyowa Kirin Inc., Kyowa Kirin Co., Ltd.

Conditions

X-linked HypophosphatemiaX-linked hypophosphatemia.

Phase 1

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

RecruitingNCT06525636

Kyowa Kirin Co., Ltd.X-linked Hypophosphatemia

Start: 2024-10-09End: 2028-05-10Target: 24Updated: 2025-11-14

A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients with X-linked Hypophosphatemia

RecruitingCTIS2023-509390-23-00

Kyowa Kirin Inc.X-linked hypophosphatemia.

Start: 2025-08-29Target: 12Updated: 2025-10-31